Pharmacogenetics and individualized therapy
著者
書誌事項
Pharmacogenetics and individualized therapy
John Wiley & Sons, c2012
大学図書館所蔵 全4件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Includes bibliographical references and index
内容説明・目次
内容説明
This resource provides thorough coverage of pharmacogenetics and its impact on pharmaceuticals, therapeutics, and clinical practice. It opens with the basics of pharmacogenetics, including drug disposition and pharmacodynamics. The following section moves into specific disease areas, including cardiovascular, psychiatry, cancer, asthma/COPD, adverse drug reactions, transplantation, inflammatory bowel disease, and pain medication. Clinical practice and ethical issues make up the third section, with the fourth devoted to technologies like genotyping, genomics, and proteomics. In the fifth part, chapters discuss the impact of key regulatory issues on the pharmaceutical industry.
目次
Preface vii
Contributors ix
1. Pharmacogenetics: A Historical Perspective 1
Ann K. Daly
Part I Pharmacogenetics: Relationship to Pharmacokinetics and Pharmacodynamics
2. Pharmacogenetics in Drug Metabolism: Role of Phase I Enzymes 15
Vita Dol an
3. Pharmacogenetics of Phase II Drug Metabolizing Enzymes 81
Ingolf Cascorbi
4. Pharmacogenetics of Drug Transporters 101
Henriette E. Meyer zu Schwabedissen, Markus Grube, and Heyo K. Kroemer
5. Pharmacogenetics of Drug Targets 149
Ann K. Daly and Maria Arranz
Part II Pharmacogenetics: Therapeutic Areas
6. Cardiovascular Pharmacogenetics 185
Bas J. M. Peters, Anthonius de Boer, Tom Schalekamp, Olaf H. Klungel, and Anke-Hilse Maitland-van der Zee
7. Pharmacogenetics in Psychiatry 215
Evangelia M. Tsapakis, Sarah Curran, Ruth I. Ohlsen, Nora S. Vyas, Katherine J. Aitchison, and Ann K. Daly
8. Pharmacogenetics in Cancer 251
Sharon Marsh
9. Pharmacogenetics of Asthma and COPD 271
Ellen S. Koster, Jan A. M. Raaijmakers, Anke-Hilse Maitland-van der Zee, and Gerard H. Koppelman
10. Pharmacogenetics of Adverse Drug Reactions 295
Ann K. Daly, Martin Armstrong, and Munir Pirmohamed
11. Pharmacogenomics of Inflammatory Bowel Diseases 323
Alexander Teml, Susanne Karner, Elke Schaeffeler, and Matthias Schwab
12. Pharmacogenetics of Pain Medication 353
Joern Loetsch
Part III Pharmacogenetics: Implementation in Clinical Practice
13. Ethical and Social Issues in Pharmacogenomics Testing 377
Susanne Vijverberg, Toine Pieters, and Martina Cornel
Part IV Developments in Pharmacogenetic Research
14. High-Throughput Genotyping Technologies for Pharmacogenetics 403
Beatriz Sobrino and Angel Carracedo
15. Developments in Analyses in Pharmacogenetic Datasets 415
Alison A. Motsinger-Reif
Part V Pharmacogenetics: Industry and Regulatory Affairs
16. Applications of Pharmacogenetics in Pharmaceutical Research and Development 439
Daniel K. Burns and Scott S. Sundseth
17. Role of Pharmacogenetics in Registration Processes 461
Myong-Jin Kim, Issam Zineh, Shiew-Mei Huang, and Lawrence J. Lesko
Part VI Conclusions
18. Pharmacogenetics: Possibilities and Pitfalls 479
Anke-Hilse Maitland-van der Zee and Ann K. Daly
Index 485
「Nielsen BookData」 より